港股早評:科技股下挫 恆科指大跌4.3% 騰訊績後開跌超6%
格隆匯5月19日丨隔夜美股重挫,滯脹擔憂進一步加劇恐慌指數飆升。港股大幅低開,恆指跌2.41%,國指跌2.8%,恆生科技指數跌4.3%。

盤面上,大型科技股集體下挫,Q1業績不及預期,騰訊跌6.46%,阿里巴巴跌5.56%,京東、小米、美團均跌超4%;消費類股跌幅靠前,餐飲股、啤酒股普遍下跌,乳製品股、汽車股、濠賭股、內房股與物管股、海運股等紛紛低開。另一方面,家電股、香港本地股、醫藥股部分上漲,亞盛醫藥大漲近15%,JS環球生活逆勢高開1.59%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.